These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2465347)

  • 1. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Vallera DA
    J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters affecting tumor-specific delivery of anti-CD5 antibody-ricin A chain immunotoxins in vivo.
    Rostaing-Capaillon O; Casellas P
    Cancer Res; 1990 May; 50(10):2909-16. PubMed ID: 1692250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of anti-CD5 radioimmunotoxins on human tumors in vitro and in a nude mouse model.
    Manske JM; Buchsbaum DJ; Hanna DE; Vallera DA
    Cancer Res; 1988 Dec; 48(24 Pt 1):7107-14. PubMed ID: 2461252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
    Press OW; Martin PJ; Thorpe PE; Vitetta ES
    J Immunol; 1988 Dec; 141(12):4410-7. PubMed ID: 2461993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
    Tonevitsky AG; Agapov II; Mechetner EB; Ershova GV; Toptygin AYu ; Sarma T; Shamshiev AT; Pfueller U
    Biochem Mol Biol Int; 1993 Dec; 31(6):1059-69. PubMed ID: 8193589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
    Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
    Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
    Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
    Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
    Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
    Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events.
    Chignola R; Anselmi C; Franceschi A; Pasti M; Candiani C; Tridente G; Colombatti M
    J Immunol; 1994 Mar; 152(5):2333-43. PubMed ID: 7510743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model.
    Leonard JE; Johnson DE; Shawler DL; Dillman RO
    Cancer Res; 1988 Sep; 48(17):4862-7. PubMed ID: 3261627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin.
    Carrière D; Casellas P; Richer G; Gros P; Jansen FK
    Exp Cell Res; 1985 Feb; 156(2):327-40. PubMed ID: 2857124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
    Pincus SH; Wehrly K; Chesebro B
    J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins.
    Fulton RJ; Uhr JW; Vitetta ES
    J Immunol; 1986 Apr; 136(8):3103-9. PubMed ID: 3958490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
    Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked difference in the in vivo antitumor efficacy between two immunotoxins targeted to different epitopes of common acute lymphoblastic leukemia antigen (CD10). Mechanisms involved in the differential activities of immunotoxins.
    Luo Y; Seon BK
    J Immunol; 1990 Sep; 145(6):1974-82. PubMed ID: 1697314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.